病态肥胖患者微创结直肠手术:体型真的重要吗?
该多中心回顾性研究分析了2006至2016年间接受微创结直肠切除术的1386例患者,其中病态肥胖(BMI≥35)84例、肥胖(30≤BMI<35)246例、非肥胖(BMI<30)1056例。三组在中转率、住院时间、吻合口漏率及30天再入院、再手术和死亡率上无差异,但病态肥胖与肥胖组手术时间和出血量高于非肥胖组。多因素回归显示BMI每增加1单位手术时间约增加2分钟,但BMI不影响中转率及并发症和死亡率。
要点
- 病态肥胖患者微创结直肠手术的中转率及短期结局与非肥胖患者相似。
- 病态肥胖与肥胖患者手术时间和出血量高于非肥胖患者。
- BMI每增加1单位手术时间约增加2分钟,但无临床显著意义。
核心结论
- 病态肥胖患者行微创结直肠手术虽手术时间和出血量增加,但中转率及短期术后结局与非肥胖患者相似。
研究设计与样本
- 多中心回顾性队列研究,纳入2006至2016年间接受微创结直肠切除术的1386例患者,其中病态肥胖84例(6%)、肥胖246例(18%)、非肥胖1056例(76%)。
主要发现
- 三组在中转率、住院时间、吻合口漏率、30天再入院率、再手术率和死亡率上无差异。
- 手术时间在三组间存在差异(病态肥胖 vs 肥胖 vs 非肥胖:185 vs 188 vs 170 min,p=0.000)。
- 出血量在三组间存在差异(病态肥胖 vs 肥胖 vs 非肥胖:20 vs 20 vs 10 ml,p=0.003)。
- 恶性肿瘤患者中,三组淋巴结检出数和R0切除率无差异。
- 单因素和多因素线性回归显示,BMI每增加1单位,手术时间约增加2分钟(单因素2.243,95%CI 1.524-2.962;多因素2.295,95%CI 1.554-3.036)。
临床怎么用
- 病态肥胖不应作为微创结直肠手术的禁忌,但需预期手术时间和出血量可能增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As obesity becomes more prevalent, it presents a technical challenge for minimally invasive colorectal resection surgery. Various studies have examined the clinical outcomes of obese surgical patients. However, morbidly obese patients (BMI ≥ 35) are becoming increasingly more common. This study aims to investigate the short-term surgical outcomes of morbidly obese patients undergoing minimal-invasive colorectal surgery and compare them with both obese (30 ≤ BMI < 35) and non-obese patients (BMI < 30). METHODS: Patients from three centres who received minimally invasive colorectal surgical resections between 2006 and 2016 were identified from prospectively collected databases. The baseline characteristics and surgical outcomes of morbidly obese, obese and non-obese patients were analysed. RESULTS: A total of 1386 patients were identified, 84 (6%) morbidly obese, 246 (18%) obese and 1056 (76%) non-obese. Patients' baseline characteristics were similar for age, operating surgeon, surgical approach but differed in terms of ASA grade and gender. There was no difference in conversion rate, length of stay, anastomotic leak rate and 30-day readmission, reoperation and mortality rates. Operation time and blood loss were different across the 3 groups (morbidly obese vs obese vs non-obese: 185 vs 188 vs 170 min, p = 0.000; 20 vs 20 vs 10 ml, p = 0.003). In patients with malignant disease there was no difference in lymph node yield or R0 clearance. Univariate and multivariate linear regression analysis showed that for every one-unit increase in BMI operative time increases by roughly 2 min (univariate 2.243, 95% CI 1.524-2.962; multivariate 2.295; 95% CI 1.554-3.036). Univariate and multivariate binary logistic regression analyses showed that BMI does not affect conversion or morbidity and mortality. CONCLUSIONS: The increased technical difficulty encountered in obese and morbidly obese patients in minimally invasive colorectal surgery results in higher operative times and blood loss, although this is not clinically significant. However, conversion rate and post-operative short-term outcomes are similar between morbidly obese, obese and non-obese patients.
引用
- Panteleimonitis S, Popeskou S, Harper M, et al. Minimally invasive colorectal surgery in the morbid obese: does size really matter? Surg Endosc. 2018. PMID: 29362912. doi:10.1007/s00464-018-6068-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。